Introduction
============

Diabetes mellitus (DM) is a group of metabolic diseases of blood glucose dysregulation that can cause complications and lead to target organ, peripheral vascular, and nerve dysfunction.[@b1-tcrm-14-2415] Previous studies showed that DM may affect the typical signs and symptoms of cervical spondylotic myelopathy[@b2-tcrm-14-2415] and could be a predisposing factor for the development of lumbar spinal stenosis.[@b3-tcrm-14-2415] Several studies have focused on the correlation between diabetes and complications of spinal surgery.[@b4-tcrm-14-2415],[@b5-tcrm-14-2415] Previous studies have shown that glycemic control could reduce the risk of postoperative mortality, surgical site infection, venous thrombosis, and a prolonged length of hospital stay after spinal surgery in patients with diabetes.[@b6-tcrm-14-2415]--[@b9-tcrm-14-2415] Appaduray and Lo[@b10-tcrm-14-2415] demonstrated that hyperglycemia could increase the risk of poor outcomes such as infections and cardiovascular disease following lumbar spinal surgery. A recent study assessed the effect of glycemic control on perioperative complications in patients undergoing lumbar surgery and showed that poor glycemic control in patients with diabetes receiving degenerative lumbar spine surgery could increase the risk of acute complications and poor outcomes.[@b11-tcrm-14-2415] However, Arnold et al[@b12-tcrm-14-2415] reported that DM would not increase the risk of postoperative complications. Controversies regarding whether diabetes could increase the rate of complications associated with spinal surgery still exist. Moreover, the sample sizes of these studies were relatively small, which could restrict the conclusions. The purpose of the present study was to conduct a meta-analysis to assess the impact of DM on surgical outcomes in patients who receive spinal surgery.

Materials and methods
=====================

Search strategy
---------------

We conducted the present study in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. A computerized search was performed in the MEDLINE database, the Cochrane CENTRAL database, ScienceDirect, EMBASE, and Google scholar for relevant published studies through May 2018. The following search terms were used to maximize the search specificity and sensitivity: spine, surgery, and diabetes. The search strategy is presented in [Figure 1](#f1-tcrm-14-2415){ref-type="fig"}, and included only studies conducted on humans for all published, unpublished, and ongoing trials. In addition, the WHO International Clinical Trials Registry Platform, the UK National Research Register Archive, and Current Controlled Trials were used for a further manual search for articles from Congresses that may have been missed in the database search from their inception to May 2018. The reference lists of all full-text papers were examined to identify any initially omitted studies.

Selection criteria
------------------

The studies that met the following criteria were included in the meta-analysis: 1) the study design was a cohort or case--control study; 2) the study included patients with and those without diabetes who were undergoing spinal surgery; 3) the study reported outcome measures, operation data, clinical function scores, recovery rates, and postoperative complications; and 4) the study may have included any other outcomes.

The exclusion criteria included reviews, letters, case reports, systematic reviews, and studies that were unrelated to our topics.

Study selection
---------------

Two authors independently screened the article titles and abstracts based on the eligibility criteria, and intensive reading of the full texts was performed when the studies met the inclusion criteria. When a study could not be excluded immediately, disagreements were resolved by consensus with the senior investigator.

Data extraction
---------------

Data extraction was conducted according to the PRISMA statement, and data from eligible peer-reviewed articles were extracted by two independent authors. Any discrepancies between the two reviewers were resolved by discussion and consensus or, if necessary, by third-party adjudication. Authors of the studies were contacted for missing data or further information when necessary. The following outcomes were extracted from the included publications: 1) demographic data on the participants; 2) operation data, clinical function scores, recovery rates, and postoperative complications; and 3) any other outcomes mentioned in the individual studies.

Assessment of methodological quality
------------------------------------

We assessed the methodological quality of included studies using the modified Newcastle--Ottawa Scale (NOS). This scale consists of three items for cohort study reports: patient selection, comparability of the intervention/control group, and outcome assessment. The quality scale ranges from 0 to 9 points. Articles were considered to be of high quality if the NOS score was \>5 points.

Statistical analysis
--------------------

We used Review Manager 5.1 software for Windows (RevMan Version 5.1; The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, Denmark) for data analysis. Dichotomous outcomes are expressed as ORs with 95% CIs; continuous outcomes are expressed as the mean differences (MDs). Before the original data were synthesized, we used Cochran's Q chi-squared test and the I[@b2-tcrm-14-2415] statistic to assess the heterogeneity across studies. *P*\<0.1 or I[@b2-tcrm-14-2415] \>50% was defined as significant heterogeneity. If substantial heterogeneity existed, a random-effects model (the DerSimonian--Laird method) was used; otherwise, a fixed-effects model (the Mantel--Haenszel method) was preferred to summarize the pooled data. When heterogeneity was present, a sensitivity analysis was conducted to identify the potential sources. Since the number of included studies was \<10, an assessment of publication bias was not performed. *P*\<0.05 was considered statistically significant.

Results
=======

Search results
--------------

The search strategy identified 738 citations as potentially relevant literature reports. By scanning the titles and abstracts, 712 reports were excluded because of duplication or irrelevancy, because they were case reports or reviews, or because they were not comparative studies. Ultimately, 24 studies[@b6-tcrm-14-2415],[@b8-tcrm-14-2415]--[@b30-tcrm-14-2415] were eligible for data extraction and meta-analysis ([Table 1](#t1-tcrm-14-2415){ref-type="table"}). No additional studies were obtained after the reference review. The search process is shown in [Figure 1](#f1-tcrm-14-2415){ref-type="fig"}.

Study characteristics
---------------------

The characteristics of the 24 included studies, which were published between 1993 and 2017, are shown in [Table 1](#t1-tcrm-14-2415){ref-type="table"}. The sample sizes of these studies ranged from 52 to 256,899 patients. Statistically similar baseline characteristics, such as the mean age and gender, were observed between both groups.

Quality assessment and level of evidence
----------------------------------------

Four of the included studies were prospective controlled studies, and 20 studies were retrospective controlled studies. The NOS scores were 5--8 for the included studies. The methodological quality assessment is presented in [Table 1](#t1-tcrm-14-2415){ref-type="table"}.

Meta-analysis outcomes
----------------------

### Blood loss

Usable data on blood loss were provided in 10 trials.[@b6-tcrm-14-2415],[@b14-tcrm-14-2415],[@b16-tcrm-14-2415],[@b18-tcrm-14-2415],[@b19-tcrm-14-2415],[@b24-tcrm-14-2415],[@b25-tcrm-14-2415],[@b27-tcrm-14-2415],[@b29-tcrm-14-2415],[@b30-tcrm-14-2415] No significant heterogeneity was observed, and a fixed-effects model was used (I[@b2-tcrm-14-2415]=36%, *P*=0.10). Pooling of the results demonstrated that blood loss in the DM group was not significantly greater than that in the non-DM group (MD=0.55, 95% CI: --8.15 to 9.26, *P*=0.90; [Figure 2](#f2-tcrm-14-2415){ref-type="fig"}).

### Operation time

The operation time was provided in eight trials.[@b6-tcrm-14-2415],[@b14-tcrm-14-2415],[@b18-tcrm-14-2415],[@b19-tcrm-14-2415],[@b24-tcrm-14-2415],[@b25-tcrm-14-2415],[@b27-tcrm-14-2415],[@b30-tcrm-14-2415] No significant heterogeneity was observed, and a fixed-effects model was used (I[@b2-tcrm-14-2415]=0%, *P*=0.47). Pooling of the results demonstrated that the operation time in the DM group was not significantly longer than that in the non-DM group (MD=1.36, 95% CI: −2.22 to 4.94, *P*=0.46; [Figure 3](#f3-tcrm-14-2415){ref-type="fig"}).

### Length of hospital stay

Data from five studies were available to examine the length of hospital stay.[@b8-tcrm-14-2415],[@b18-tcrm-14-2415],[@b24-tcrm-14-2415],[@b27-tcrm-14-2415],[@b29-tcrm-14-2415] Significant heterogeneity was observed, and a random-effects model was used (I[@b2-tcrm-14-2415]=91%, *P*\<0.001). Pooling of the results demonstrated that the length of hospital stay in the DM group was significantly longer than that in the non-DM group (MD=1.00, 95% CI: 0.29--1.71, *P*=0.02; [Figure 4](#f4-tcrm-14-2415){ref-type="fig"}).

### Mortality

Six studies reported postoperative mortality.[@b8-tcrm-14-2415],[@b9-tcrm-14-2415],[@b11-tcrm-14-2415],[@b18-tcrm-14-2415],[@b20-tcrm-14-2415],[@b29-tcrm-14-2415] No significant heterogeneity was observed (I[@b2-tcrm-14-2415]=0%, *P*=0.48); therefore, a fixed-effects model was used. Pooling of the results demonstrated that the incidence of postoperative mortality in the DM group was significantly higher than that in the non-DM group (OR=1.44, 95% CI: 1.33--1.56, *P*\<0.001; [Figure 5](#f5-tcrm-14-2415){ref-type="fig"}).

### Reoperation

The number of patients who underwent reoperation was provided in six studies.[@b12-tcrm-14-2415],[@b16-tcrm-14-2415],[@b19-tcrm-14-2415],[@b22-tcrm-14-2415],[@b27-tcrm-14-2415],[@b30-tcrm-14-2415] No significant heterogeneity was observed (I[@b2-tcrm-14-2415]=0%, *P*=0.56); therefore, a fixed-effects model was used. Pooling of the results demonstrated that the incidence of reoperation in the DM group was not significantly higher than that in the non-DM group (OR=1.18, 95% CI: 0.99--1.40, *P*=0.07; [Figure 6](#f6-tcrm-14-2415){ref-type="fig"}).

### Infection

Seventeen studies reported the postoperative incidence of infection.[@b8-tcrm-14-2415]--[@b13-tcrm-14-2415],[@b15-tcrm-14-2415],[@b18-tcrm-14-2415]--[@b21-tcrm-14-2415],[@b24-tcrm-14-2415]--[@b27-tcrm-14-2415],[@b29-tcrm-14-2415],[@b30-tcrm-14-2415] Significant heterogeneity was observed, and a random-effects model was used (I[@b2-tcrm-14-2415]=61%, *P*=0.0005). The meta-analysis revealed that the postoperative incidence of infection was significantly higher than that in the non-DM group (OR=1.88, 95% CI: 1.46--2.42, *P*\<0.001; [Figure 7](#f7-tcrm-14-2415){ref-type="fig"}).

### Deep venous thrombosis (DVT)

Five studies reported the postoperative incidence of DVT.[@b8-tcrm-14-2415],[@b11-tcrm-14-2415],[@b12-tcrm-14-2415],[@b19-tcrm-14-2415],[@b20-tcrm-14-2415] No significant heterogeneity was observed, and a fixed-effects model was used (I[@b2-tcrm-14-2415]=6%, *P*=0.37). The meta-analysis revealed that the postoperative incidence of DVT was significantly higher than that in the non-DM group (OR=1.49, 95% CI: 1.40--1.58, *P*\<0.001; [Figure 8](#f8-tcrm-14-2415){ref-type="fig"}).

Discussion
==========

The present study indicates that diabetes increases the risks of postoperative mortality, surgical site infection, DVT, and prolonged hospitalization time after spinal surgery. Four prospective controlled studies and 20 retrospective controlled studies were included. Although the NOS scores of the included studies are high (ranging from 5 to 8), the limitations inherent in this methodology weakened the level of evidence and should be considered when interpreting the findings of the present meta-analysis.

In 2010, the number of deaths caused by DM reached approximately 1.3 million worldwide, and the disease burden is several times greater in the elderly.[@b11-tcrm-14-2415],[@b31-tcrm-14-2415] A large proportion of patients undergoing degenerative spine surgery are elderly, and therefore the impact of DM on surgical outcomes is of great interest. Currently, only a few studies have described the outcomes of spinal surgery in patients with DM. However, previous reports have relatively small sample sizes, which limit the conclusions that can be widely applied to clinical practice.[@b6-tcrm-14-2415],[@b7-tcrm-14-2415],[@b30-tcrm-14-2415]

Our meta-analysis demonstrates that patients with diabetes undergoing spinal surgery had increased odds of mortality. However, there is no clear and direct evidence to confirm that DM is an independent risk factor for postoperative mortality. Comorbidities including cardiovascular and cerebrovascular diseases, respiratory diseases, urinary system diseases, and nervous system diseases may have had additional influences on the outcomes for patients following spinal surgery, according to some studies.[@b11-tcrm-14-2415],[@b12-tcrm-14-2415],[@b18-tcrm-14-2415],[@b25-tcrm-14-2415] Guzman et al[@b11-tcrm-14-2415] and Farrell and Moran[@b32-tcrm-14-2415] indicated that people with DM are more likely to have these comorbidities. Furthermore, Hamdan et al[@b33-tcrm-14-2415] and Carson et al[@b34-tcrm-14-2415] reported that comorbidities could increase inpatient mortality following spinal surgery. Therefore, a significant difference exists between the mortality rate of patients with diabetes undergoing spinal surgery and that of patients without diabetes.

No significant difference was found in the reoperation rate between patients with and without DM following spinal surgery. The reasons for reoperation included dysphagia (following cervical operation), malpositioning of the implant, or a postoperative deformity. Some studies[@b12-tcrm-14-2415],[@b19-tcrm-14-2415] have shown that reoperation is not closely related to the presence of diabetes.

We also found that the risk of surgical site infection and DVT was higher in patients with DM following spinal surgery than in patients without DM. Many risk factors affect wound healing, including a lack of platelet-derived growth factor, neutropenia, tissue hypoxia, and microvascular disease.[@b35-tcrm-14-2415],[@b36-tcrm-14-2415] In addition, fibroblasts and collagen deficiency can lead to delayed wound healing.[@b37-tcrm-14-2415] Immune dysfunction is caused by the effects of DM increasing the probability of infection of the surgical site. DM is a chronic systemic disease characterized by high concentrations of glucose in the blood. Jones and Mitchell[@b38-tcrm-14-2415] also reported that a high concentration of glucose in blood vessels leads to increased vascular endothelial damage, which results in a higher risk of venous thrombosis. Therefore, patients with DM are more likely to develop venous thrombosis than those without DM following spinal surgery.

The results showed no significant difference in the operation time or blood loss between patients with and those without diabetes following spinal surgery, which is consistent with the results of several studies.[@b6-tcrm-14-2415],[@b16-tcrm-14-2415],[@b18-tcrm-14-2415],[@b19-tcrm-14-2415],[@b24-tcrm-14-2415],[@b27-tcrm-14-2415],[@b29-tcrm-14-2415],[@b30-tcrm-14-2415] However, the length of hospital stay for patients with DM was longer than that for patients without diabetes, which may be related to the treatment of surgical site infections and other complications. Some papers have reported that the prolonged hospitalization time is related to the further regulation of blood glucose.[@b27-tcrm-14-2415]

There are some limitations in our meta-analysis: 1) no specific type of DM has a greater impact on spinal surgery, and it is not known whether spinal surgery will affect HbA1c; 2) the small sample sizes in the literature may have affected the final results; 3) differences in diabetes duration, treatment, complications, or comorbidities could have affected the findings and, similarly, the definition of diabetes was not standardized across the included studies and therefore it is likely that each study cohort may have affected the findings of the study; 4) this article did not compare the various types of spinal surgeries in detail, and different surgical methods may prolong the operation time and increase blood loss and the probability of surgical site infections, which may have impacted the evaluated results; and 5) most of the studies were performed on patients of the same nationality, and the lack of a regional comparison may affect the generalization of the results.

Conclusion
==========

The effect of spinal surgery in patients with DM is more prominent and serious than that in patients without diabetes, and the mortality rate, surgical site infection rate, risk of venous thrombosis, and length of hospital stay are increased in patients with diabetes. Given this finding, physicians should pay attention to this risk to avoid complications.
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###### 

Characteristics of included studies

  Author                                       Study design    Diagnosis                                            Operative interventions      Sample size   Mean age (years)   NOS               
  -------------------------------------------- --------------- ---------------------------------------------------- ---------------------------- ------------- ------------------ -------- -------- ---
                                                                                                                                                                                                    
  Appaduray and Lo 2013[@b10-tcrm-14-2415]     Retrospective   Lumbar spondylolisthesis/spinal stenosis/scoliosis   Decompression/fusion         115           444                66.5     54       7
  Arinzon et al 2004[@b13-tcrm-14-2415]        Retrospective   Lumbar spinal stenosis                               Decompression                62            62                 70.5     72.4     7
  Arnold et al 2014[@b12-tcrm-14-2415]         Prospective     Cervical spondylotic myelopathy                      Decompression                42            236                60.12    55.66    8
  Armaghani et al 2016[@b14-tcrm-14-2415]      Prospective     NS                                                   Decompression/fusion         434           571                61       56       8
  Browne et al 2007[@b8-tcrm-14-2415]          Retrospective   NS                                                   Fusion                       11,135        186,326            48.96             5
  Chen et al 2009[@b15-tcrm-14-2415]           Retrospective   NS                                                   Fusion                       30            165                NS       NS       6
  Cho et al 2012[@b16-tcrm-14-2415]            Retrospective   Thoracolumbar deformity                              Spine corrective operation   23            23                 61.1     59.2     8
  Cook et al 2008[@b9-tcrm-14-2415]            Retrospective   Cervical spondylotic myelopathy                      Fusion                       3,432         34,300             60.48    54.23    7
  Dokai et al 2012[@b17-tcrm-14-2415]          Retrospective   Cervical spondylotic myelopathy                      Laminoplasty                 13            65                 72       71.1     7
  Freedman et al 2011[@b18-tcrm-14-2415]       Retrospective   Lumbar spondylolisthesis/spinal stenosis             Discectomy/decompression     117           1,464              NS       NS       7
  Glassman et al 2003[@b19-tcrm-14-2415]       Retrospective   NS                                                   Fusion                       94            43                 63       59       6
  Golinvaux et al 2014[@b20-tcrm-14-2415]      Retrospective   NS                                                   Decompression/fusion         2,437         13,043             NS       NS       7
  Guzman et al 2014[@b11-tcrm-14-2415]         Retrospective   Degenerative disease                                 Decompression/fusion         423,050       2,145,944          NS       NS       8
  Hikata et al 2014[@b21-tcrm-14-2415]         Retrospective   Degenerative disease/vertebral fracture/scoliosis    Fusion                       36            309                64.3     63.8     7
  Kawaguchi et al 2000[@b6-tcrm-14-2415]       Retrospective   Cervical spondylotic myelopathy                      Laminoplasty                 18            34                 65.7     64.8     6
  Kim et al 2015[@b22-tcrm-14-2415]            Prospective     NS                                                   Decompression/fusion         6,268         28,650             NS       NS       8
  Kim et al 2008[@b23-tcrm-14-2415]            Retrospective   Cervical spondylotic myelopathy                      Laminoplasty                 31            56                 64.7     61.1     7
  Liao et al 2006[@b24-tcrm-14-2415]           Retrospective   Degenerative spondylolisthesis                       Fusion                       39            298                60--70   60--70   7
  Machino et al 2014[@b25-tcrm-14-2415]        Prospective     Cervical spondylotic myelopathy                      Laminoplasty                 115           444                66.5     54       7
  Maloney et al 2017[@b26-tcrm-14-2415]        Retrospective   Lumbar disc herniation                               Discectomy                   126           126                59       59       6
  Sharma et al 2013[@b27-tcrm-14-2415]         Retrospective   NS                                                   Decompression/fusion         111           97                 62       63       7
  Silverstein et al, 2016[@b28-tcrm-14-2415]   Retrospective   Degenerative disease/vertebral fracture/scoliosis    Lumbar decompression         30            182                NS       NS       7
  Simpson et al 1993[@b29-tcrm-14-2415]        Retrospective   Lumbar disc herniation/spinal stenosis               Decompression/fusion         62            62                 63       63       6
  Takahashi et al 2013[@b30-tcrm-14-2415]      Retrospective   Lumbar disc herniation/spinal stenosis               Decompression/fusion         41            124                70.9     68       8

**Abbreviations:** DM, diabetes mellitus; NOS, Newcastle--Ottawa Scale; NS, not state.
